SCHEMBL27188666

SCHEMBL27188666

CCc1ccc(-c2nc3ccc(Br)cc3n2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.45
▸ ALDH1A1 P00352 6/20 0.42
▸ RAB9A P51151 6/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ TP53 P04637 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ PKM P14618 3/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20982482 0.89 ALDH1A1 (0.50) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL27188343 0.89 NPC1 (0.53) PPARGALDH1A1RAB9ANPC1TP53
SCHEMBL26603188 0.88 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL27188325 0.83 KDM4E (0.56) PPARGALDH1A1RAB9ANPC1TP53
SCHEMBL26603143 0.82 CYP11B1 (0.53) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL20982762 0.82 ATM (0.53) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL26603181 0.81 MEN1 (0.62) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL17973875 0.79 ALDH1A1 (0.67) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL10424045 0.78 ALDH1A1 (0.58) ALDH1A1RAB9ANPC1TP53KDM4E
SCHEMBL27188360 0.78 PPARG (0.63) PPARGRAB9ANPC1CHEK2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109850-A1 Covalent PPARG inverse-agonists BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109850-A1 Covalent PPARG inverse-agonists PPARG, PPARD, PPARA PPARG 1/4885ALDH1A1 1224/4885RAB9A 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback